332 related articles for article (PubMed ID: 26164183)
1. Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT.
Takahashi M; Kume H; Koyama K; Nakagawa T; Fujimura T; Morikawa T; Fukayama M; Homma Y; Ohtomo K; Momose T
Clin Nucl Med; 2015 Dec; 40(12):936-40. PubMed ID: 26164183
[TBL] [Abstract][Full Text] [Related]
2. Dual-tracer PET/CT in renal angiomyolipoma and subtypes of renal cell carcinoma.
Ho CL; Chen S; Ho KM; Chan WK; Leung YL; Cheng KC; Wong KN; Cheung MK; Wong KK
Clin Nucl Med; 2012 Nov; 37(11):1075-82. PubMed ID: 22996247
[TBL] [Abstract][Full Text] [Related]
3. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.
Minamimoto R; Nakaigawa N; Nagashima Y; Toyohara J; Ueno D; Namura K; Nakajima K; Yao M; Kubota K
Abdom Radiol (NY); 2016 Mar; 41(3):521-30. PubMed ID: 27039323
[TBL] [Abstract][Full Text] [Related]
5. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
[TBL] [Abstract][Full Text] [Related]
6. Restaging clear cell renal carcinoma with 18F-FDG PET/CT.
Fuccio C; Ceci F; Castellucci P; Spinapolice EG; Palumbo R; D'Ambrosio D; Bernardo A; Brunocilla E; Schiavina R; Maffione AM; Chondrogiannis S; Grassetto G; Colletti PM; Rubello D; Fanti S; Trifirò G
Clin Nucl Med; 2014 Jun; 39(6):e320-4. PubMed ID: 24566409
[TBL] [Abstract][Full Text] [Related]
7. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of Clear Cell Renal Cell Carcinoma From Other Subtypes and Fat-Poor Angiomyolipoma by Use of Quantitative Enhancement Measurement During Three-Phase MDCT.
Kim SH; Kim CS; Kim MJ; Cho JY; Cho SH
AJR Am J Roentgenol; 2016 Jan; 206(1):W21-8. PubMed ID: 26700359
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of rapid kV-switching dual energy CT in renal tumor characterization.
Çamlıdağ İ; Nural MS; Danacı M; Özden E
Abdom Radiol (NY); 2019 May; 44(5):1841-1849. PubMed ID: 30637472
[TBL] [Abstract][Full Text] [Related]
10. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
[TBL] [Abstract][Full Text] [Related]
12. Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer.
Mizuno T; Kamai T; Abe H; Sakamoto S; Kitajima K; Nishihara D; Yuki H; Kambara T; Betsunoh H; Yashi M; Fukabori Y; Kaji Y; Yoshida K
BMC Cancer; 2015; 15():1097. PubMed ID: 25784113
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula.
Kopp RP; Aganovic L; Palazzi KL; Cassidy FH; Sakamoto K; Derweesh IH
Can J Urol; 2013 Jun; 20(3):6790-7. PubMed ID: 23783049
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma.
Hou G; Zhao D; Jiang Y; Zhu Z; Huo L; Li F; Cheng W
Cancer Imaging; 2021 Feb; 21(1):25. PubMed ID: 33632314
[TBL] [Abstract][Full Text] [Related]
15. FDG PET or PET/CT in evaluation of renal angiomyolipoma.
Lin CY; Chen HY; Ding HJ; Yen KY; Kao CH
Korean J Radiol; 2013; 14(2):337-42. PubMed ID: 23483018
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG-PET/CT in potentially advanced renal cell carcinoma: a role in treatment decisions and prognosis estimation.
Ferda J; Ferdova E; Hora M; Hes O; Finek J; Topolcan O; Kreuzberg B
Anticancer Res; 2013 Jun; 33(6):2665-72. PubMed ID: 23749925
[TBL] [Abstract][Full Text] [Related]
17. Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma?
Yang CW; Shen SH; Chang YH; Chung HJ; Wang JH; Lin AT; Chen KK
AJR Am J Roentgenol; 2013 Nov; 201(5):1017-28. PubMed ID: 24147472
[TBL] [Abstract][Full Text] [Related]
18. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
19. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of oncocytoma and renal cell carcinoma in small renal masses (<4 cm): the role of 4-phase computerized tomography.
Bird VG; Kanagarajah P; Morillo G; Caruso DJ; Ayyathurai R; Leveillee R; Jorda M
World J Urol; 2011 Dec; 29(6):787-92. PubMed ID: 20717829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
